Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks General Information Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

China Ups Role of Hospital Pharmacy Affairs as NRDL Negotiation Concludes Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on government's latest shift to upgrade hospital pharmacy af... (8/1/2017) Can Tax Breaks Boost Private Health Insurance in China? (8/15/2017) New Research Compares Drug Regulators Around the Globe (8/15/2017) Beijing Courts Issued Consequential Judgments On Life-Science Patents (8/15/2017) China's Proposed Control of Biological Resources Alerts Korean Drugmakers (8/10/2017) China Joins ICH in Pursuit of Global Harmonization of Drug Development Standards (8/10/2017) Ten Years and $100M+ Later, GSK Shutters a China R&D Site amid Reorganization (8/8/2017) BeyondSpring Pharma: Communicating Across US-China Lines (8/8/2017) FDA Proposes Patent Linkage Mechanism and Terms for Data Exclusivity for Public Comments (8/8/2017) China Ups Role of Hospital Pharmacy Affairs as NRDL Negotiation Concludes (8/1/2017) Review of Chinese Pharma Deals, R&D and Regulatory Developments in H1/2017 (8/1/2017) Cancer in the Asia-Pacific, a CRO Perspective (7/13/2017) Fast-tracking the Introduction of New Drugs (7/13/2017) Branded Generics in the Emerging Markets (7/12/2017) FT: Fosun Shares Slide As Group Denies Loss of Contact With Chairman (7/7/2017) Why Big Pharma Is Targeting China's Deadliest Diseases (7/5/2017) CFDI to Initiate Clinical Data Inspectio...  (8/18/2017) CFDA Approves BMS's Baraclude as First P...  (8/18/2017) CFDA Issues Announcement to Clarify Over...  (8/18/2017) Ascletis In-licenses Medivir's Novel HCV...  (8/18/2017) 50 Domestically-listed Chinese Pharma Co...  (8/18/2017) WuXi Biologics and Gloria Pharma Outlice...  (8/17/2017) Recent Executive Moves  (8/17/2017) GSK, AliHealth Join Hands to Build Vacci...  (8/17/2017) China Sets Up New IP Rights Center for M...  (8/17/2017) (free) Prometic Seals Joint Venture and Licensi...  (8/16/2017) Zai Lab Files for NASDAQ IPO  (8/16/2017) Smoking-unrelated Lung Cancer Jumps in C...  (8/16/2017) Antengene Raises $21M in Series A Financ...  (8/15/2017) (free) HitGen, Aduro Form New Drug Discovery Pa...  (8/15/2017) China Issues Interpretations for Applica...  (8/15/2017) White House Task Force Echoes Pharma Proposals Pharma Industry Reputation Rebounds Somewhat in 2016 Fresenius Steps Up Pharma M&A with Akorn, Merck KGaA... Global Pharmerging Market to Grow at a CAGR of 12.88% in... PhRMA Urges USTR to Protect US Innovation Abroad Chinese Human Vaccine Market To Rise Quickly Before 2021 The APAC Colorectal Cancer Market Set to Grow by 7.9% CAGR Befo... Review of Chinese Retail Pharmacy Sales 2013-2016 Chinese Cancer Intervention Market to Grow Double-Digits Nicholas Hall Reports MAT Q1/2017 Data on the Chinese OTC / OTC... CFDA Approves BMS's Baraclude as First Pediatric HBV Drug in... Ascletis In-licenses Medivir's Novel HCV Drug Candidate 50 Domestically-listed Chinese Pharma Companies Report H1 Pe... WuXi Biologics and Gloria Pharma Outlicense PD-1 Antibody to... GSK, AliHealth Join Hands to Build Vaccine Promotion Channel... CFDI to Initiate Clinical Data Inspection of 32 Drug Pro... CFDA Issues Announcement to Clarify Over Published Refer... NDRC Solicits Comments on Pricing Guideline for Shortage... CFDA Issues National Drug Abuse Monitoring Annual Report... China to Introduce Price Guidelines for APIs of Shortage... China Sets Up New IP Rights Center for Manufacturing and Bio... China Issues Interpretations for Application of Criminal Law... USTR Promises Thorough Investigation of China's IP Practices... China Moves Up to No. 22 in 2017 Global Innovation Index NDRC Penalizes Two More Monopolistic API Producers French Authority Warns Chongqing API Producer over GMP V... Another Chinese API Producer in Data Integrity Mudpool a... U.S. FDA Warns Chinese API Producer for Absence of Writt... India to Make Key APIs to Reduce Dependence on China DSM Sinochem Pharmaceuticals Boosts Manufacturing Capaci... NIH Quietly Proposes to Grant Salubris Rights to A Portf... Tyme Receives Notice of Allowance of Patent for SM-88 in... DelMar Pharma Cleared to Initiate Phase 2 Clinical Trial... SillaJen and Lee's Pharma Approved to Commence Phase III... China Accepts Propanc Biopharma's Patent Application for... Smoking-unrelated Lung Cancer Jumps in China Lung Cancer Incidence Jumps in China with Smog Blamed First Expert Committee of National Clinical Medicine Res... NHFPC Holds 2017 National Drug Administrative Conference... State Council Issues Guidance Opinion for Modern Hospita... Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves Recent Executive Moves Upcoming Event: Annual Biopharma Innovation Conference 2... Sino-Japanese Symposium on Pharmaceuticals and Medical D... Upcoming Event: Biopharma Development & Producti... Upcoming Event: 4th Annual PharmaCon Asia Upcoming Event: ISPE Conference and Exhibition 2017 Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Its...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links